Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral…
Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The…
Read More...
Read More...
